Medindia
About ▼ Careers Internship MedBlog Contact us
English (US) ▼
Medindia
LOGIN REGISTER
Advertisement

DSM Nutritional Products Announces First Human Data on resVida(R) Trans-resveratrol Which Demonstrates Potential Cardiovascular Health Benefits

Tuesday, December 8, 2009 Heart Disease News
Advertisement
Data Presented at 4th International Conference on Polyphenols and Health and The Nutrition Society of Australia and Nutrition Society of New Zealand Joint Annual Scientific Meeting

For media inquiries please contact:

William J. Brown

Communications

DSM Nutritional Products, Inc.

Tel:  +1 973 257 8266

E-mail: [email protected]

Catherine London

Resolute Communications

Tel: +1 212 213 8533

E-mail: [email protected]

Sponsored Post and Backlink Submission


Latest Press Release on Heart Disease News

From 'the big one' to big relief for Adena Health heart attack patient
CHILLICOTHE, Ohio ,  April 23, 2024 /PRNewswire/ -- Jesse Patterson has always been more of a self-treatment type of guy when it comes to dealing with his health. So, when the nor...
11th International Conference on Interventional Cardiology
We are pleased to announce the 11th International Conference on Interventional Cardiology scheduled to take place on October 24-25 2024 in the picturesque city of Zurich Switzerland. This co...
Texas Cardiac Arrhythmia Institute at St. David's Medical Center first in U.S. to use FDA-approved pulsed field ablation system
AUSTIN, Texas , April 9, 2024 /PRNewswire/ -- Electrophysiologists at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center became the first in the nation to use...
Aquedeon Medical Announces First Patient Enrolled in the IDE Study of Duett(TM) Vascular Graft System
SUNNYVALE, Calif. , March 18, 2024 /PRNewswire/ -- Aquedeon Medical, Inc., a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is please...
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
HANGZHOU, China , March 7, 2024 /PRNewswire/ -- Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in...
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close